enow.com Web Search

  1. Ad

    related to: factor viii manufacturers

Search results

  1. Results from the WOW.Com Content Network
  2. Factor VIII - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII

    Coagulation factor VIII (Factor VIII, FVIII, also known as anti-hemophilic factor (AHF)) is an essential blood clotting protein. In humans, it is encoded by F8 gene . [ 5 ] [ 6 ] Defects in this gene result in hemophilia A , an X-linked bleeding disorder .

  3. Factor VIII (medication) - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII_(medication)

    A purified factor VIII concentrate is made from human blood plasma. [14] A recombinant version is also available. [13] People may develop antibodies to factor VIII such that this medication becomes less effective. [15] Factor VIII was first identified in the 1940s and became available as a medication in the 1960s.

  4. Contaminated haemophilia blood products - Wikipedia

    en.wikipedia.org/wiki/Contaminated_haemophilia...

    Hemophilia A causes a deficiency in Factor VIII, a protein required for blood clotting. Factor VIII injections are a common treatment to prevent or stop bleeding in people with hemophilia A. [1] Contamination of these and other products caused large numbers of hemophiliacs to become infected with HIV and hepatitis C.

  5. Octapharma - Wikipedia

    en.wikipedia.org/wiki/Octapharma

    Octapharma was founded in 1983 by Wolfgang Marguerre, a German businessman who had previously worked in the pharmaceutical industry. The name Octapharma is derived from the Greek word for eight, referring to Factor VIII, the blood clotting protein deficient in patients with haemophilia A.

  6. Swedish Orphan Biovitrum - Wikipedia

    en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum

    This partnership was extended the following year to also include the development of a long-lasting recombinant factor VIII Fc fusion protein candidate, rFVIIIFc, for the treatment of hemophilia A. In 2008, an agreement with Amgen regarding the acquisition of the products Kepivance and Stemgen as well as a global license for Kineret was signed

  7. Efmoroctocog alfa - Wikipedia

    en.wikipedia.org/wiki/Efmoroctocog_alfa

    Efmoroctocog alfa, sold under the brand name Elocta among others, is a medication for the treatment and prophylaxis of bleeding in people with hemophilia A. [5] [6] [7] Efmoroctocog alfa is a recombinant human coagulation factor VIII, Fc fusion protein (rFVIIIFc). [5]

  8. Efanesoctocog alfa - Wikipedia

    en.wikipedia.org/wiki/Efanesoctocog_alfa

    Efanesoctocog alfa is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for routine prophylaxis to reduce the frequency of bleeding episodes; on-demand treatment & control of bleeding episodes; and perioperative management of bleeding.

  9. Moroctocog alfa - Wikipedia

    en.wikipedia.org/wiki/Moroctocog_alfa

    It replaces the missing factor VIII, thereby helping the blood to clot and giving temporary control of bleeding. [6] The human coagulation factor VIII in moroctocog alfa is not extracted from human blood but is produced by a method known as 'recombinant DNA technology': it is made by a cell that has received a gene (DNA), which makes it able to ...

  1. Ad

    related to: factor viii manufacturers